{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T15:16:33Z","timestamp":1787584593244,"version":"build-2736575974"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T00:00:00Z","timestamp":1610409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,1,12]],"date-time":"2021-01-12T00:00:00Z","timestamp":1610409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the Project of Guangzhou Science Technology and Innovation Commission","award":["201707010122"],"award-info":[{"award-number":["201707010122"]}]},{"DOI":"10.13039\/100007847","name":"Natural Science Foundation of Jilin Province","doi-asserted-by":"crossref","award":["2017A030313829,2018A030313449"],"award-info":[{"award-number":["2017A030313829,2018A030313449"]}],"id":[{"id":"10.13039\/100007847","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012232","name":"National Key Clinical Specialty Discipline Construction Program of China","doi-asserted-by":"crossref","award":["2017YFC0907700"],"award-info":[{"award-number":["2017YFC0907700"]}],"id":[{"id":"10.13039\/501100012232","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009398","name":"International Foundation for Functional Gastrointestinal Disorders","doi-asserted-by":"crossref","award":["2015B050501003"],"award-info":[{"award-number":["2015B050501003"]}],"id":[{"id":"10.13039\/100009398","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Guangdong Provincial Engineering Center For Major Neurological Disease Treatment"},{"DOI":"10.13039\/100016101","name":"Guangdong Provincial Translational Medicine Innovation Platform for Diagnosis and Treatment of Major Neurological Disease","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100016101","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Guangdong Provincial Clinical Research Center for Neurological Diseases"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Introduction<\/jats:title>\n                <jats:p>This study investigated the characteristics of double-seropositive myasthenia gravis (DSP-MG) in southern China for disease subtype classification.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A case-control study was carried out in which the characteristics of DSP-MG patients (<jats:italic>n<\/jats:italic>\u00a0=\u200917) were compared to those of muscle-specific tyrosine kinase antibody-positive (MuSK)-MG and acetylcholine receptor antibody-positive (AChR)-MG patients (<jats:italic>n<\/jats:italic>\u00a0=\u20098 and 27, respectively). We also performed a literature review of DSP-MG patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Compared to AChR-MG, DSP-MG had greater bulbar dysfunction (47.1% vs 18.6%, <jats:italic>P<\/jats:italic>\u00a0=\u20090.04), higher incidence of myasthenia crisis (41.2% vs 14.8%, <jats:italic>P<\/jats:italic>\u2009=\u20090.04), more severe Myasthenia Gravis Foundation of America classification at maximum worsening, greater autoantibody abnormalities (70.6% vs 33.3%, <jats:italic>P<\/jats:italic>\u00a0=\u20090.015), greater need for immunosuppressant treatment (58.8% vs 3.7%, <jats:italic>P<\/jats:italic>\u00a0&lt;\u20090.001), and worse prognosis with less remission (11.8% vs 55.6%, <jats:italic>P<\/jats:italic>\u00a0=\u20090.001). There were no differences between DSP-MG and MuSK-MG patients. DSP-MG described in published reports was comparable to MuSK-MG.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>DSP-MG in southern China may be a subtype of MuSK-MG.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s10072-021-05042-3","type":"journal-article","created":{"date-parts":[[2021,1,13]],"date-time":"2021-01-13T14:22:16Z","timestamp":1610547736000},"page":"863-869","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["AChRAb and MuSKAb double-seropositive myasthenia gravis: a distinct subtype?"],"prefix":"10.1007","volume":"42","author":[{"given":"Jieni","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weibin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1153-5919","authenticated-orcid":false,"given":"Huiyu","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,12]]},"reference":[{"key":"5042_CR1","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S1474-4422(15)00145-3","volume":"14","author":"NE Gilhus","year":"2015","unstructured":"Gilhus NE, Verschuuren JJ (2015) Myasthenia gravis: subgroup classification and therapeutic strategies. Lancet Neurol 14:1023\u20131036","journal-title":"Lancet Neurol"},{"key":"5042_CR2","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jneuroim.2015.04.015","volume":"284","author":"AI Tsonis","year":"2015","unstructured":"Tsonis AI, Zisimopoulou P, Lazaridis K, Tzartos J, Matsigkou E (2015) Zouvelou, et al. MuSK autoantibodies in myasthenia gravis detected by cell based assay--a multinational study. J Neuroimmunol 284:10\u201317","journal-title":"J Neuroimmunol"},{"key":"5042_CR3","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1159\/000212372","volume":"26","author":"S Muppidi","year":"2009","unstructured":"Muppidi S, Wolfe GI (2009) Muscle-specific receptor tyrosine kinase antibody-positive and seronegative myasthenia gravis. Front Neurol Neurosci 26:109\u2013119","journal-title":"Front Neurol Neurosci"},{"key":"5042_CR4","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1097\/WCO.0b013e32833c0982","volume":"23","author":"JT Guptill","year":"2010","unstructured":"Guptill JT, Sanders DB (2010) Update on muscle-specific tyrosine kinase antibody positive myasthenia gravis. Curr Opin Neurol 23:530\u2013535","journal-title":"Curr Opin Neurol"},{"key":"5042_CR5","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1111\/ene.12169","volume":"20","author":"R Nakata","year":"2013","unstructured":"Nakata R, Motomura M, Masuda T, Shiraishi H, Tokuda M, Fukuda T et al (2013) Thymus histology and concomitant autoimmune diseases in Japanese patients with muscle-specific receptor tyrosine kinase-antibody-positive myasthenia gravis [J]. Eur J Neurol 20:1272\u20131276","journal-title":"Eur J Neurol"},{"issue":"2","key":"5042_CR6","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1097\/CND.0b013e318275197c","volume":"14","author":"JO Shin","year":"2012","unstructured":"Shin JO, Morgan MB, Lu L, Hatanaka Y, Hemmi S et al (2012) Different characteristic phenotypes according to antibody in myasthenia Gravis [J]. J Clin Neuromuscul Dis 14(2):57\u201365","journal-title":"J Clin Neuromuscul Dis"},{"key":"5042_CR7","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/ncpneuro0526","volume":"3","author":"J Diaz-Manera","year":"2007","unstructured":"Diaz-Manera J, Rojas-Garcia R, Gallardo E, Juarez C, Martinez-Domeno A, Martinez-Ramirez S et al (2007) Antibodies to AChR, MuSK and VGKC in a patient with myasthenia gravis and Morvan\u2019s syndrome. Nat Clin Pract Neurol 3:405\u2013410","journal-title":"Nat Clin Pract Neurol"},{"key":"5042_CR8","first-page":"354","volume":"04","author":"L Yuan","year":"2015","unstructured":"Yuan L, Lan C, Yi-fan Z (2015) The detection and clinical characteristics of serum positive of MuSK-Ab and double-seronegative in patients with MG. J Apoplex Nervous Dis 04:354\u2013356","journal-title":"J Apoplex Nervous Dis"},{"key":"5042_CR9","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.jneuroim.2012.05.011","volume":"250","author":"K Poulas","year":"2012","unstructured":"Poulas K, Koutsouraki E, Kordas G, Kokla A, Tzartos SJ (2012) Anti-MuSK- and anti-AChR-positive myasthenia gravis induced by d-penicillamine. J Neuroimmunol 250:94\u201398","journal-title":"J Neuroimmunol"},{"key":"5042_CR10","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.jneuroim.2013.12.012","volume":"267","author":"V Zouvelou","year":"2014","unstructured":"Zouvelou V, Zisimopoulou P, Psimenou E, Matsigkou E, Stamboulis E, Tzartos SJ (2014) AChR-myasthenia gravis switching to double-seropositive several years after the onset. J Neuroimmunol 267:111\u2013112","journal-title":"J Neuroimmunol"},{"key":"5042_CR11","doi-asserted-by":"publisher","first-page":"E129","DOI":"10.1002\/mus.26040","volume":"57","author":"V Zouvelou","year":"2018","unstructured":"Zouvelou V (2018) Double Seropositive Myasthenia Gravis: A 5-Year Follow-Up. Muscle Nerve 57:E129","journal-title":"Muscle Nerve"},{"key":"5042_CR12","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1016\/j.clinph.2006.03.028","volume":"117","author":"A Rostedt Punga","year":"2006","unstructured":"Rostedt Punga A, Ahlqvist K, Bartoccioni E, Scuderi F, Marino MB, Suomalainen A et al (2006) Neurophysiological and mitochondrial abnormalities in MuSK antibody seropositive myasthenia gravis compared to other immunological subtypes. Clin Neurophysiol 117:1434\u20131443","journal-title":"Clin Neurophysiol"},{"key":"5042_CR13","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/s00415-015-7982-2","volume":"263","author":"B Jordan","year":"2016","unstructured":"Jordan B, Schilling S, Zierz S (2016) Switch to double positive late onset MuSK myasthenia gravis following thymomectomy in paraneoplastic AChR antibody positive myasthenia gravis. J Neurol 263:174\u2013176","journal-title":"J Neurol"},{"key":"5042_CR14","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1007\/s00415-009-5215-2","volume":"256","author":"A Kostera-Pruszczyk","year":"2009","unstructured":"Kostera-Pruszczyk A, Kwiecinski H (2009) Juvenile seropositive myasthenia gravis with anti-MuSK antibody after thymectomy. J Neurol 256:1780\u20131781","journal-title":"J Neurol"},{"key":"5042_CR15","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1007\/s00415-012-6661-9","volume":"259","author":"S Rajakulendran","year":"2012","unstructured":"Rajakulendran S, Viegas S, Spillane J, Howard RS (2012) Clinically biphasic myasthenia gravis with both AChR and MuSK antibodies. J Neurol 259:2736\u20132739","journal-title":"J Neurol"},{"key":"5042_CR16","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1002\/mus.23645","volume":"47","author":"V Zouvelou","year":"2013","unstructured":"Zouvelou V, Kyriazi S, Rentzos M, Belimezi M, Micheli MA, Tzartos SJ et al (2013) Double-seropositive myasthenia gravis. Muscle Nerve 47:465\u2013466","journal-title":"Muscle Nerve"},{"key":"5042_CR17","doi-asserted-by":"publisher","first-page":"668","DOI":"10.4103\/0028-3886.68687","volume":"58","author":"H Suhail","year":"2010","unstructured":"Suhail H, Vivekanandhan S, Singh S, Behari M (2010) Coexistent of muscle specific tyrosine kinase and acetylcholine receptor antibodies in a myasthenia gravis patient. Neurol India 58:668\u2013669","journal-title":"Neurol India"},{"key":"5042_CR18","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1212\/01.wnl.0000267694.45244.f4","volume":"69","author":"B Saulat","year":"2007","unstructured":"Saulat B, Maertens P, Hamilton WJ, Bassam BA (2007) Anti-musk antibody after thymectomy in a previously seropositive myasthenic child. Neurology 69:803\u2013804","journal-title":"Neurology"},{"key":"5042_CR19","first-page":"258","volume":"28","author":"C Wei","year":"2015","unstructured":"Wei C (2015) One cases of antibody of AChR and MuSK double seropositive myasthenia gravis. Journal of Clinical Neurology in Chinese 28:258\u2013261","journal-title":"Journal of Clinical Neurology in Chinese"},{"key":"5042_CR20","unstructured":"Ju L, Zhiyun L, Hongxi C, Ziyan S, Huiru F, Xiaohui M, et al. West China Medical Journal in Chinese 2018; 33:696\u2013702"},{"issue":"5","key":"5042_CR21","doi-asserted-by":"publisher","first-page":"e165","DOI":"10.1016\/j.clinph.2006.07.265","volume":"118","author":"A Al Saleh","year":"2007","unstructured":"Al Saleh A, Cariga P (2007) Myasthenia gravis with AChR and MuSK antibodies positivity: case report. Clinical Neurophysiology 118(5):e165","journal-title":"Clinical Neurophysiology"},{"issue":"11","key":"5042_CR22","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/j.nmd.2013.07.010","volume":"23","author":"KL Skjei","year":"2013","unstructured":"Skjei KL, Lennon VA, Kuntz NL (2013) Muscle specific kinase autoimmune myasthenia gravis in children: a case series. Neuromuscul Disord 23(11):874\u2013882","journal-title":"Neuromuscul Disord"},{"key":"5042_CR23","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jneuroim.2008.05.032","volume":"201\u2013202","author":"DB Sanders","year":"2008","unstructured":"Sanders DB, Juel VC (2008) MuSK-antibody positive myasthenia gravis: questions from the clinic. J Neuroimmunol 201\u2013202:85\u201389","journal-title":"J Neuroimmunol"},{"key":"5042_CR24","first-page":"167","volume":"03","author":"F Xin-xin","year":"2013","unstructured":"Xin-xin F (2013) Detection and significance of anti-AchR antibodies and anti-MuSK antibodies in serum of myasthenia gravis. J. Med. Sci. Yanbian Univ 03:167\u2013169","journal-title":"J. Med. Sci. Yanbian Univ"},{"key":"5042_CR25","first-page":"69","volume":"172","author":"L Mingqiang","year":"2008","unstructured":"Mingqiang L, Lu R, Yingna Z, Jie L, Hua F, Jing Z et al (2008) Clinical characteristics of AChRAb and MuSKAb double seropositive myasthenia gravis patients. Clinical Neurology and Neurosurgery 172:69\u201373","journal-title":"Clinical Neurology and Neurosurgery"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-021-05042-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10072-021-05042-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-021-05042-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,9]],"date-time":"2021-02-09T07:45:52Z","timestamp":1612856752000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10072-021-05042-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,12]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["5042"],"URL":"https:\/\/doi.org\/10.1007\/s10072-021-05042-3","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,12]]},"assertion":[{"value":"15 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Institutional review board approval of our hospital was obtained for this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All patients involved in this study gave their informed consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"We confirm that we have read the Journal\u2019s position on issues involved in ethical publication and affirm that this report is consistent with those guidelines.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical publication statement"}}]}}